Expanding excellence in vision care: Welcoming Tanya Alvares to John Rose Eye Care, Kingston Upon Thames, London

At John Rose Eye Care, we continue to redefine clinical excellence in independent optometry by expanding our world-class team and clinical services. We are proud to welcome two esteemed professionals to our Kingston Upon Thames  London clinic: Tanya Alvares, BSc (Hons) MCOptom and Dr. Zimar Sivardeen, MBA, PhD, FBCLA, FCOptom, FEAOO. These highly regarded Optometrists …

Read More

Valeda LDS – the first and ONLY FDA-authorised treatment for dry AMD to improve vision!

A New Era in Macular Degeneration Care – Safe, Effective and Non-Invasive 🔹 Key Highlights ✅ Rigorous Clinical Trials: LightSite II and LightSite III confirmed effectiveness. ✅ FDA-Approved (November 2024): The first and only treatment using photobiomodulation (PBM) for AMD to receive FDA approval. FDA Approval Announcement ✅Proven Track Record: Over 750,000 treatments performed worldwide…

Read More

Discover the Latest in Dry AMD Treatment with John Rose Optometrist

​ Join optometrist John Rose in conversation with journalist Angela Young as they discuss the FDA-approved Valeda Light Delivery System (LDS) treatment for Dry Age-Related Macular Degeneration (AMD). Hear directly from John and Alita, one of our AMD patients, about how this innovative therapy works and their personal experience with Valeda. 🎧✨ Listen to the…

Read More

The Valeda LDS treatment for dry AMD is now FDA approved

LumiThera has received U.S. FDA authorisation to market its Valeda® Light Delivery System, the first FDA-approved treatment for vision loss due to dry age-related macular degeneration (AMD). The non-invasive photobiomodulation (PBM) device demonstrated improved visual acuity and safety over 24 months in the pivotal LIGHTSITE III trial, with results showing that Valeda slowed disease progression…

Read More

Valeda LDS, the treatment for patients suffering from Dry Age-Related Macular Degeneration

Managing Dry Macular Degeneration (AMD) Age-Related Macular Degeneration is a gradual loss of vision that progresses with age. It normally affects central vision, particularly contrast sensitivity, dark adaptation, colour vision and depth perception – changes that influence performance and experience of day-to-day tasks and hobbies such as reading, driving, watching TV, painting etc. Early stages…

Read More